MPWT
RXRX icon

MassMutual Private Wealth & Trust’s Recursion Pharmaceuticals RXRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.1K Buy
3,853
+494
+15% +$1.65K ﹤0.01% 1249
2026
Q1 		$10.3K Sell
3,359
-31
-0.9% -$120 ﹤0.01% 1356
2025
Q4 		$13.9K Sell
3,390
-146
-4% -$723 ﹤0.01% 1261
2025
Q3 		$17.3K Buy
3,536
+436
+14% +$2.29K ﹤0.01% 1180
2025
Q2 		$15.7K Buy
3,100
+600
+24% +$2.95K ﹤0.01% 1203
2025
Q1 		$13.2K Buy
2,500
+400
+19% +$2.92K ﹤0.01% 1191
2024
Q4 		$14.2K Hold
2,100
– – ﹤0.01% 1126
2024
Q3 		$13.8K Hold
2,100
– – ﹤0.01% 1026
2024
Q2 		$15.8K Buy
+2,100
New +$18.3K ﹤0.01% 927

Other funds holding RXRX

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
KG
Kieckhefer Group Mequon, Wisconsin $246M AUM 51.29% 1-Year Est. Return
TMC
Themes Management Co Greenwich, Connecticut $151M AUM
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
AWM
Accel Wealth Management Waverly, Iowa $444M AUM 31.14% 1-Year Est. Return
NWMG
National Wealth Management Group Cincinnati, Ohio $323M AUM 39.23% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $3.65B AUM 26.64% 1-Year Est. Return

MassMutual Private Wealth & Trust's RXRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust increased its Recursion Pharmaceuticals (RXRX) stake by 15% in Q2 2026, buying an estimated $1.65K and bringing the position to 3,853 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1249.

MassMutual Private Wealth & Trust first reported a position in RXRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $17.3K in Q3 2025. 35 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 3,853 shares of Recursion Pharmaceuticals worth $14.1K as of Q2 2026.
  • MassMutual Private Wealth & Trust bought 494 Recursion Pharmaceuticals shares in Q2 2026, an estimated $1.65K.
  • Recursion Pharmaceuticals made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1249 holding.
  • MassMutual Private Wealth & Trust first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • MassMutual Private Wealth & Trust's Recursion Pharmaceuticals position peaked at $17.3K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.